Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2423 vs placebo in posttraumatic neuralgia
2010-019785-90Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-traumatic neuralgia comparing AZD2423 with Placebo (2 arms). Primary endpoint: Change from baseline in mean NRS Average Pain Score. Started Jul 2010; status: completed.
02
Drugs
azd2423
03
Conditions
post-traumatic neuralgia
Beyond the preview
Go deeper on 2010-019785-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019785-90.